GlassScriptPhysician profile
Joseph Michael Carda
NPI 1962884197
$3,519.44
in general payments reported to CMS, 2019-2025
11 companies · $190 in 2025
The $190 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,493 · 2020: $134 · 2021: $208 · 2022: $38.52 · 2023: $1,404 · 2024: $52.25 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,066 · Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,066.30 |
| Food and Beverage | $579.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,885.56 | 2019-2023 | Superion Indirect Decompression System, Patient Trial Kit |
| Medtronic USA, INC. | $956.17 | 2019 | |
| Merck Sharp & Dohme LLC | $199.39 | 2019-2020 | |
| Abbott Laboratories | $124.56 | 2019-2025 | Eterna |
| Nevro Corp. | $83.34 | 2021 | |
| Medtronic, INC. | $78.81 | 2024-2025 | Synchromedii, Intellis Adaptivestim |
| Takeda Pharmaceuticals U.S.A., INC. | $70.20 | 2025 | Entyvio |
| Vertiflex, INC. | $58.30 | 2019 | |
| Hologic Sales and Service, LLC | $34.80 | 2025 | Fluent Fluid Management System |
| Averitas Pharma INC. | $15.40 | 2023 | Qutenza |
| Collegium Pharmaceutical, INC. | $12.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Carda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.